180 related articles for article (PubMed ID: 36544680)
41. Endocrine disorders among long-term survivors of childhood head and neck rhabdomyosarcoma.
Clement SC; Schoot RA; Slater O; Chisholm JC; Abela C; Balm AJM; van den Brekel MW; Breunis WB; Chang YC; Davila Fajardo R; Dunaway D; Gajdosova E; Gaze MN; Gupta S; Hartley B; Kremer LCM; van Lennep M; Levitt GA; Mandeville HC; Pieters BR; Saeed P; Smeele LE; Strackee SD; Ronckers CM; Caron HN; van Santen HM; Merks JHM
Eur J Cancer; 2016 Feb; 54():1-10. PubMed ID: 26707591
[TBL] [Abstract][Full Text] [Related]
42. Intensity-modulated proton and carbon-ion radiation therapy in the management of major salivary gland carcinomas.
Huang Q; Hu W; Hu J; Gao J; Yang J; Qiu X; Kong L; Lu JJ
Ann Transl Med; 2022 Nov; 10(22):1195. PubMed ID: 36544665
[TBL] [Abstract][Full Text] [Related]
43. Particle Reirradiation of Malignant Epithelial and Neuroectodermal Sinonasal Tumors: A Case Series from CNAO.
Vischioni B; Ingargiola R; Bonora M; Ronchi S; Camarda AM; Russo S; Rossi E; Magro G; Mirandola A; Orlandi E
J Clin Med; 2023 Mar; 12(7):. PubMed ID: 37048714
[TBL] [Abstract][Full Text] [Related]
44. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
45. Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy.
Iannalfi A; D'Ippolito E; Riva G; Molinelli S; Gandini S; Viselner G; Fiore MR; Vischioni B; Vitolo V; Bonora M; Ronchi S; Petrucci R; Barcellini A; Mirandola A; Russo S; Vai A; Mastella E; Magro G; Maestri D; Ciocca M; Preda L; Valvo F; Orecchia R
Neuro Oncol; 2020 Sep; 22(9):1348-1358. PubMed ID: 32193546
[TBL] [Abstract][Full Text] [Related]
46. A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma.
Fang P; Gunther JR; Pinnix CC; Dong W; Strati P; Nastoupil LJ; Steiner RE; Ahmed S; Damron EP; Fowler N; Nair R; Westin JR; Neelapu S; Ha CS; Dabaja BS
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1414-1420. PubMed ID: 33309978
[TBL] [Abstract][Full Text] [Related]
47. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
48. Parameningeal rhabdomyosarcoma: outcomes and opportunities.
Yang JC; Wexler LH; Meyers PA; Wolden SL
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e61-6. PubMed ID: 23021437
[TBL] [Abstract][Full Text] [Related]
49. Local control after intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.
Curtis AE; Okcu MF; Chintagumpala M; Teh BS; Paulino AC
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):173-7. PubMed ID: 18501529
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and feasibility of re-irradiation using carbon ions for pancreatic cancer that recurs after carbon-ion radiotherapy.
Hagiwara Y; Yamada S; Isozaki Y; Takiyama H; Shinoto M; Kawashiro S; Bhattacharyya T; Nemoto K; Tsuji H
Clin Transl Radiat Oncol; 2021 Jan; 26():24-29. PubMed ID: 33294643
[TBL] [Abstract][Full Text] [Related]
51. Outcomes of orbital malignancies treated with eye-sparing surgery and adjuvant particle radiotherapy: a retrospective study.
Hu W; Hu J; Gao J; Yang J; Qiu X; Kong L; Lu JJ
BMC Cancer; 2019 Aug; 19(1):776. PubMed ID: 31387548
[TBL] [Abstract][Full Text] [Related]
52. Proton therapy for pediatric head and neck malignancies.
Vogel J; Both S; Kirk M; Chao HH; Bagatell R; Li Y; Womer R; Balamuth N; Reilly A; Kurtz G; Lustig R; Tochner Z; Hill-Kayser C
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29058370
[TBL] [Abstract][Full Text] [Related]
53. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
54. The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience.
Cai X; Du Y; Wang Z; Li P; Yu Z; Zhang Q; Zhang Z
Radiat Oncol; 2020 Aug; 15(1):209. PubMed ID: 32859234
[TBL] [Abstract][Full Text] [Related]
55. A clinicopathologic study of head and neck rhabdomyosarcomas showing FOXO1 fusion-positive alveolar and MYOD1-mutant sclerosing are associated with unfavorable outcome.
Owosho AA; Huang SC; Chen S; Kashikar S; Estilo CL; Wolden SL; Wexler LH; Huryn JM; Antonescu CR
Oral Oncol; 2016 Oct; 61():89-97. PubMed ID: 27688110
[TBL] [Abstract][Full Text] [Related]
56. The impact of radiotherapy on clinical outcomes in parameningeal rhabdomyosarcoma.
Choi Y; Lim DH
Radiat Oncol J; 2016 Dec; 34(4):290-296. PubMed ID: 27609110
[TBL] [Abstract][Full Text] [Related]
57. Two-Year Toxicity and Efficacy of Carbon Ion Radiotherapy in the Treatment of Localized Prostate Cancer: A Single-Centered Study.
Li P; Hong Z; Li Y; Fu S; Zhang Q
Front Oncol; 2021; 11():808216. PubMed ID: 35223457
[TBL] [Abstract][Full Text] [Related]
58. Non-parameningeal head and neck rhabdomyosarcoma in children, adolescents, and young adults: Experience of the European paediatric Soft tissue sarcoma Study Group (EpSSG) - RMS2005 study.
Glosli H; Bisogno G; Kelsey A; Chisholm JC; Gaze M; Kolb F; McHugh K; Shipley J; Gallego S; Merks JHM; Smeele LE; Mandeville H; Ferrari A; Minard-Colin V; Corradini N; Jenney M; Zanetti I; De Salvo GL; Orbach D;
Eur J Cancer; 2021 Jul; 151():84-93. PubMed ID: 33971448
[TBL] [Abstract][Full Text] [Related]
59. Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses.
Phan J; Sio TT; Nguyen TP; Takiar V; Gunn GB; Garden AS; Rosenthal DI; Fuller CD; Morrison WH; Beadle B; Ma D; Zafereo ME; Hutcheson KA; Kupferman ME; William WN; Frank SJ
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):30-41. PubMed ID: 27325480
[TBL] [Abstract][Full Text] [Related]
60. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]